Epratuzumab And Rituximab Have Different Modes Of Action
14th Nov 2006, 13:31 GMT
Immunomedics, Inc. (Nasdaq: IMMU), a biopharmaceutical company focused on developing monoclonal antibodies, today reported that studies have shown that epratuzumab and rituximab have distinct mechanisms of action - epratuzumab acts as an immunomodulatory agent while rituximab is an acutely cytotoxic therapeutic antibody with different modes of action. [click link for full article]
Epratuzumab And Rituximab Have Different Modes Of Action related news:
- Epratuzumab and Rituximab Have Different Modes of Action — Bio-Technology News from StratCenter.com
- FDA Allows Resumption of Lupus Trials with Epratuzumab — PR Newswire: All Releases
- New Sketchfighter 4000 Alpha Screenshots — Inside Mac Games
- Action by rail staff called off — Scotsman.com News - Scotland
- Repeat Treatment With MabThera Provides Continuous Improvement Of Quality Of Life In Rheumatoid Arthritis Patients — Health News from Medical News Today
- Zimbabwe: Unity in Action is the Way Forward — AllAfrica News: Editorials
- Cook just gets in to the action — NBA Player News : CBS SportsLine.com
- Tough on the causes of crime — BBC News | Programmes | Law in Action | UK Edition
- Babcock settles insider dealing action — The Irish Times' Top Stories
- Unreal Tournament 2004 Unreal Demolition Public Beta 5 Mod — Gamespot Recent Updates [PC]
Latest news from Health News from Medical News Today:
- Biotech Industry Welcomes WHO Initiative On Naming Of Biologicals Including Biosimilar Medicines
- Common Cause Of Heart Disease, Diabetes May Be Treatable With Malaria Drug
- Two Nerve Cells In Direct Contact
- Value Of 'Helper' Compound In Treating Some Leukemias
- Internists Take Home Several National Awards At AAMC Annual Meeting
- Most Canadian Med School Grads Lack Basic Surgical Skills
- ACP's Electronic Medical Resource Ranked No. 1 Evidence-based Tool By MLA's South Central Chapter
- University Of Illinois Scientist Helping Processors Keep E. Coli Out Of Meat
- American Thoracic Society Publishes New Statement On Hepatotoxicity Of Antituberculosis Therapy
- Neural Networking Nanotubes